23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

EQT leads €9.6bn buyout of Qiagen

Swedish investment firm EQT is poised to make a major acquisition in the diagnostics sector with a 9.6 billion euro bid for Dutch company Qiagen.
Advertisement

Qiagen has around 5,600 employees worldwide and is a leading provider of technologies and tests for molecular diagnostics and genetic analysis, a field in which demand has grown rapidly in recent years.

The company is known for its technologies for DNA, RNA and molecular diagnostics, which are widely used in research, clinical diagnostics and precision medicine.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.032|